Physician profile
Paul Keetae Kim
NPI 1639362700
$1,538,381.77
in general payments reported to CMS, 2019-2025
28 companies · $407K in 2025
The $407K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146K · 2020: $155K · 2021: $183K · 2022: $180K · 2023: $208K · 2024: $261K · 2025: $407K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $433K · Royalty Or License: $240K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $151K · Travel and Lodging: $38K · Food and Beverage: $12K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $433,494.42 |
| Royalty Or License | $240,487.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150,731.25 |
| Travel and Lodging | $37,908.95 |
| Food and Beverage | $12,378.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $629,499.74 | 2019-2025 | Altera, Corbel, Creo 5.5 |
| Medtronic, INC. | $628,460.42 | 2021-2025 | Cd Horizon Spinal System, Clydesdale Ptc Spinal System, Pivox Oblique Lateral Spinal System |
| Nuvasive, INC. | $194,227.35 | 2019-2023 | Archon, Xlif, Alif |
| Bioventus LLC | $37,019.79 | 2019-2025 | Nexus-10 Mkii |
| Medtronic USA, INC. | $21,578.75 | 2019-2020 | |
| Boston Scientific Corporation | $9,095.93 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Surgalign Spine Technologies, INC. | $5,850.00 | 2020 | |
| Medical Device Business Services, INC. | $4,095.00 | 2023 | Symphony |
| Alphatec Spine, INC | $2,914.21 | 2025 | Other - Miscellaneous |
| Mirus, LLC | $1,622.88 | 2019 | |
| Stryker Corporation | $1,260.27 | 2022-2025 | Everest Spinal System, Es2 Spinal System, Mako |
| Vb Spine LLC | $1,160.01 | 2025 | Everest Spinal System, Napa Access System |
| Depuy Synthes Products, INC. | $432.17 | 2023 | Velys |
| Depuy Synthes Sales INC. | $365.04 | 2019-2025 | Symphony, Expedium, Confidence Spinal Cement System |
| Cerapedics INC. | $166.91 | 2022-2025 | I-Factor Peptide Enhanced Bone Graft |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $148.10 | 2020-2024 | Floseal |
| Intrinsic Therapeutics | $145.19 | 2021-2023 | Barricaid Acd (Annular Closure Device) |
| Spine Wave, INC. | $97.93 | 2025 | Spinal Implant |
| Djo, LLC | $71.20 | 2025 | Cmf |
| Saluda Medical Americas, INC. | $43.86 | 2023 | Evoke Scs |
| Dilon Technologies, INC. | $29.90 | 2025 | Hemoblast Bellows |
| Exelixis INC. | $23.64 | 2025 | Cabometyx |
| Covidien Lp | $21.81 | 2019 | |
| Genentech USA, INC. | $20.99 | 2023 | Tecentriq, Alecensa, Avastin |
| Si-Bone, INC. | $16.38 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $14.30 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.